Swedish Orphan Biovitrum AB (B6E)

You seem to being reverting to your old cynical self. Give XERI a chance to at least get a copy of the final certification report before deciding that the whole 5-year-long exercise was a total waste of time and money.

From a FB post. Credit: Julie Slama, Randy Gottula and pictures from Joel Dunekache.



https://investorshub.advfn.com/uimage/uploads/2026/6/18/dgmuyIMG_4472.JPG
https://investorshub.advfn.com/uimage/uploads/2026/6/18/pvgavIMG_4471.JPG
https://investorshu

CTNT on the move here $2.42,$2.60,$3.16 next resistance levels

TIPS volume in

Huge insider buys last week

I doubt it it's profit taking. it could be people needing money to pay for things or playing other stocks in the meantime while they wait

$1.94 on watch for FDA same story as OTLK

Taking some haircuts today.. deservedly so

BEGI on life support

CRVO, today’s screamer takes a while for the leader to emerge

MGAM~~crazyy breakout,low float,140%%up

…lets recover and run into long weekend - we got AriZona baby! One guy dumping out aint nothing as i think many hundreds wait on sidelines for a dip like this.

Not quite sure but its been on the FTD page for months, is this what delivering failures looks like?

https://www.nasdaqtrader.com/trader.aspx?id=regshothreshold

THH booooom

THH booooom

MSTX/MSTR now 15% of account...swing batta swing!

Looking forward to a great 2026 as the weather warms up and home building accelerates.

So you sleep in finally, crawl over to the NLST thread and then try and steal my thounder ???

he's traveling to the Bahamas with our money right?

BATL doubled $1.17

$MWWC I think we are close for a nice bump. A good PR or tweet from Blagman and we run over .001 in my opinion. Good bid support and not many .0003’s.

$ENSC .27 should be receiving a $5 million grant this month per website:
MPAR® Program Update: PF614-MPAR
The current grant extends through 2027, with a third $5 million installment expected in June 2026.
https://ir.ensysce.com/news/press-releases/detail/206/ensysce-biosciences-

LGVN 0.83 final data readout in August if positive this could be a 1000% opportunity from current market cap of 26million dollar . The drug could be approved by next year and could receive priority review voucher upon FDA approval which alone is worth ~ 160million dollar.

https://res.

Yet many repetitive posts everyday.... so something must be upcoming

Those investors in Neveracure never learn,
https://finance.yahoo.com/healthcare/articles/novocure-announces-topline-data-phase-110000210.html